Haplotype and quantitative transcript analyses of Portuguese breast/ovarian cancer families with the BRCA1 R71G founder mutation of Galician origin
- PMID: 19123044
- DOI: 10.1007/s10689-008-9229-1
Haplotype and quantitative transcript analyses of Portuguese breast/ovarian cancer families with the BRCA1 R71G founder mutation of Galician origin
Abstract
We investigated the functional effect of the missense variant c.211A>G (R71G) localized at position -2 of exon 5 donor splice site in the BRCA1 gene and evaluated whether Portuguese and Galician families with this mutation share a common ancestry. Three unrelated Portuguese breast/ovarian cancer families carrying this variant were studied through qualitative and quantitative transcript analyses. We also evaluated the presence of loss of heterozigosity and the histopathologic characteristics of the carcinomas in those families. Informative families (two from Portugal and one from Galicia) were genotyped for polymorphic microsatellite markers flanking BRCA1 to reconstruct haplotypes. Qualitative RNA analysis revealed the presence of two alternative transcripts both in carriers of the BRCA1 R71G variant and in controls. Semi-quantitative fragment analysis and real-time RT-PCR showed a significant increase of the transcript with an out of frame deletion of the last 22nt of exon 5 (BRCA1-Delta22ntex5) and a decrease of the full-length transcript (BRCA1-ex5FL) in patients carrying the R71G mutation as compared to controls, whereas no significant differences were found for the transcript with in frame skipping of exon 5 (BRCA1-Deltaex5). One haplotype was found to segregate in the two informative Portuguese families and in the Galician family. We demonstrate that disruption of alternative transcript ratios is the mechanism causing hereditary breast/ovarian cancer associated with the BRCA1 R71G mutation. Furthermore, our findings indicate a common ancestry of the Portuguese and Galician families sharing this mutation.
Similar articles
-
The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript.Hum Mutat. 2001 Jun;17(6):520-1. doi: 10.1002/humu.1136. Hum Mutat. 2001. PMID: 11385711
-
Pathological splice mutations outside the invariant AG/GT splice sites of BRCA1 exon 5 increase alternative transcript levels in the 5' end of the BRCA1 gene.Oncogene. 2002 Jun 13;21(26):4171-5. doi: 10.1038/sj.onc.1205520. Oncogene. 2002. PMID: 12037674
-
Mutations and alternative splicing of the BRCA1 gene in UK breast/ovarian cancer families.Genes Chromosomes Cancer. 1997 Feb;18(2):102-10. Genes Chromosomes Cancer. 1997. PMID: 9115959
-
Haplotype analysis of the internationally distributed BRCA1 c.3331_3334delCAAG founder mutation reveals a common ancestral origin in Iberia.Breast Cancer Res. 2020 Oct 21;22(1):108. doi: 10.1186/s13058-020-01341-3. Breast Cancer Res. 2020. PMID: 33087180 Free PMC article.
-
BRCA1-No Matter How You Splice It.Cancer Res. 2019 May 1;79(9):2091-2098. doi: 10.1158/0008-5472.CAN-18-3190. Epub 2019 Apr 16. Cancer Res. 2019. PMID: 30992324 Free PMC article. Review.
Cited by
-
Genetic Cancer Risk Assessment for Breast Cancer in Latin America.Rev Invest Clin. 2017 Mar-Apr;69(2):94-102. doi: 10.24875/ric.17002195. Rev Invest Clin. 2017. PMID: 28453507 Free PMC article. Review.
-
BRCA1/ATF1-Mediated Transactivation is Involved in Resistance to PARP Inhibitors and Cisplatin.Cancer Res Commun. 2021 Nov 12;1(2):90-105. doi: 10.1158/2767-9764.CRC-21-0064. eCollection 2021 Nov. Cancer Res Commun. 2021. PMID: 36860287 Free PMC article.
-
Biogeographical origin and timing of the founder ichthyosis TGM1 c.1187G > A mutation in an isolated Ecuadorian population.Sci Rep. 2019 May 9;9(1):7175. doi: 10.1038/s41598-019-43133-6. Sci Rep. 2019. PMID: 31073126 Free PMC article.
-
Germline mutations in BRCA1, BRCA2, CHEK2 and TP53 in patients at high-risk for HBOC: characterizing a Northeast Brazilian Population.Hum Genome Var. 2014 Oct 16;1:14012. doi: 10.1038/hgv.2014.12. eCollection 2014. Hum Genome Var. 2014. PMID: 27081505 Free PMC article.
-
Using Portuguese BRCA pathogenic variation as a model to study the impact of human admixture on human health.BMC Genomics. 2024 Apr 27;25(1):416. doi: 10.1186/s12864-024-10311-4. BMC Genomics. 2024. PMID: 38671360 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous